Related references
Note: Only part of the references are listed.Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130
Oh-Joon Kwon et al.
ONCOGENE (2022)
Macrophages Cytokine Spp1 Increases Growth of Prostate Intraepithelial Neoplasia to Promote Prostate Tumor Progression
Justin K. Messex et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
Felix Weiss et al.
NATURE REVIEWS CANCER (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
Izhar Singh Batth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prostate cancer
Richard J. Rebello et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
Banglian Hu et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation
Yu-Chih Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
Nazia Riaz et al.
CANCERS (2021)
Tumor-Associated Macrophage Promotes the Survival of Cancer Cells upon Docetaxel Chemotherapy via the CSF1/CSF1R-CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer
Wei Guan et al.
GENES (2021)
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder
Young H. Lee et al.
PLOS ONE (2021)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Karen A. Autio et al.
CLINICAL CANCER RESEARCH (2020)
The M-CSF receptor in osteoclasts and beyond
Se Hwan Mun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
Varintra E. Krisnawan et al.
CANCERS (2020)
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
Hannah R. Moorman et al.
CANCERS (2020)
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer
Xiaolong Shi et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
Ying Zhu et al.
GUT (2019)
Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
Xiaocong Pang et al.
FRONTIERS IN ONCOLOGY (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications
Archana Kumari et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The role of osteopontin in the progression of solid organ tumour
Hailin Zhao et al.
CELL DEATH & DISEASE (2018)
Macrophages orchestrate breast cancer early dissemination and metastasis
Nina Linde et al.
NATURE COMMUNICATIONS (2018)
CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer
Kazuharu Kai et al.
SCIENTIFIC REPORTS (2018)
Colony-stimulating factor-1 receptor provides a growth advantage in epithelial cancer cell line A431 in the presence of epidermal growth factor receptor inhibitor gefitinib
Svenja Ellen Niehus et al.
CELLULAR SIGNALLING (2018)
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma
Orsi Giricz et al.
JCI INSIGHT (2018)
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Luigi Mario Castello et al.
MEDIATORS OF INFLAMMATION (2017)
Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression
X. Zhao et al.
ONCOGENESIS (2017)
Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling
Amy R. Dwyer et al.
CANCERS (2017)
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer
Daniela Achkova et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells
A. Patsialou et al.
ONCOGENE (2015)
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells
V. Barbetti et al.
ONCOGENE (2014)
Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation
M. Cioce et al.
CELL DEATH & DISEASE (2014)
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes
Florian Kahles et al.
MOLECULAR METABOLISM (2014)
Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152
Ho-Hyung Woo et al.
MOLECULAR CANCER (2013)
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
Autocrine CSF-1 and CSF-1 Receptor Coexpression Promotes Renal Cell Carcinoma Growth
Julia Menke et al.
CANCER RESEARCH (2012)
CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways
Kellie A. Mouchemore et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2012)
Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110δ isoform of PI 3-kinase
Olivier Zwaenepoel et al.
FASEB JOURNAL (2012)
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
Andrea Morandi et al.
PLOS ONE (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation
T. Chihara et al.
CELL DEATH AND DIFFERENTIATION (2010)
Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells
Melodie L. Knowlton et al.
PLOS ONE (2010)
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
Antonia Patsialou et al.
CANCER RESEARCH (2009)
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells
John T. Lee et al.
CELL CYCLE (2008)
In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression
Maria Cecilia G. Marcondes et al.
CELLULAR IMMUNOLOGY (2008)
The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma
E. Richardsen et al.
HISTOPATHOLOGY (2008)
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome
Haishan Lin et al.
SCIENCE (2008)
Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains
Julien Grassot et al.
MOLECULAR BIOLOGY AND EVOLUTION (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity
SG Gosse et al.
CELLULAR SIGNALLING (2005)
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop
S Goswami et al.
CANCER RESEARCH (2005)
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture
CN Wrobel et al.
JOURNAL OF CELL BIOLOGY (2004)
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model
HM Kluger et al.
LABORATORY INVESTIGATION (2004)
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis
HM Kluger et al.
CLINICAL CANCER RESEARCH (2004)
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
H Ide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects
XM Dai et al.
BLOOD (2002)
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
JE Green et al.
ONCOGENE (2000)
Share Paper
